银江技术(300020) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥508,969,316.12, a slight increase of 0.24% compared to ¥507,725,465.84 in the same period last year[3] - Net profit attributable to shareholders decreased by 13.36% to ¥50,006,253.77 from ¥57,717,285.51 year-on-year[3] - The net profit after deducting non-recurring gains and losses increased by 7.07% to ¥49,477,765.96 compared to ¥46,209,771.29 in the previous year[3] - The basic earnings per share decreased by 11.11% to ¥0.08 from ¥0.09 in the same period last year[3] - The diluted earnings per share also decreased by 11.11% to ¥0.08 from ¥0.09 year-on-year[3] - The weighted average return on equity was 1.44%, down from 1.64% in the previous year[3] - Total operating revenue for Q1 2022 was CNY 508,969,316.12, a slight increase from CNY 507,725,465.84 in Q1 2021, representing a growth of 0.25%[21] - Net profit for Q1 2022 was CNY 48,893,784.29, down from CNY 56,759,176.03 in the same period last year, indicating a decline of about 13.3%[22] - Earnings per share (basic and diluted) for Q1 2022 were both CNY 0.08, compared to CNY 0.09 in Q1 2021[23] - The total comprehensive income for Q1 2022 was CNY 48,893,784.29, down from CNY 74,447,944.03 in the previous year, indicating a decline of about 34.3%[22] Cash Flow - The net cash flow from operating activities improved significantly, reaching -¥61,845,978.71, an 84.40% increase from -¥396,391,183.96 in the same period last year[3] - The cash inflow from operating activities for the current period was ¥702,950,222.23, an increase of 14.8% compared to ¥612,220,885.86 in the previous period[24] - The total cash outflow from operating activities was ¥764,796,200.94, a decrease of 24.2% from ¥1,008,612,069.82 in the previous period[24] - The total cash inflow from operating activities included ¥603,666,311.05 from sales of goods and services, an increase from ¥546,354,338.79 in the previous period[24] - The cash inflow from investment activities was ¥16,000,000.00, a decrease of 91.9% from ¥197,476,300.00 in the previous period[26] - The net cash flow from investment activities was ¥14,307,942.61, down from ¥196,126,531.45 in the previous period[26] - The cash inflow from financing activities was ¥450,564,942.79, a decrease of 2.6% compared to ¥461,319,562.79 in the previous period[26] - The net cash flow from financing activities was -¥173,898,376.55, worsening from -¥156,340,900.63 in the previous period[26] - The ending balance of cash and cash equivalents was ¥132,806,442.00, down from ¥277,243,600.71 in the previous period[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,480,477,730.94, a decrease of 1.65% from ¥6,589,119,675.96 at the end of the previous year[3] - Total liabilities decreased to CNY 2,951,473,260.03 from CNY 3,109,008,989.34, reflecting a reduction of about 5.08%[19] - Shareholders' equity attributable to the parent company increased by 1.45% to ¥3,500,818,953.06 from ¥3,450,812,699.29 at the end of the previous year[3] - The total current assets decreased from CNY 4,488,279,292.89 at the beginning of the year to CNY 4,393,882,999.58 by the end of the quarter, reflecting a decline of approximately 2.1%[17] - Cash and cash equivalents dropped significantly from CNY 425,997,510.12 to CNY 228,692,696.51, a decrease of about 46.3%[17] - Accounts receivable increased slightly from CNY 1,891,057,204.26 to CNY 1,892,482,584.41, indicating a growth of approximately 0.1%[17] - Inventory rose from CNY 39,601,069.70 to CNY 54,169,769.85, marking an increase of about 36.7%[17] - The long-term equity investment increased from CNY 589,944,044.61 to CNY 591,982,868.36, reflecting a growth of approximately 0.3%[17] Investments and Projects - The company reported non-recurring gains of ¥528,487.81, primarily from government subsidies and other income[5] - The company is involved in the PPP project for the Shenyang Regional Population Health Information Platform, which was officially launched in December 2019 and is currently in its second year of operation[13] - The company has a contract worth CNY 27,580,000 for the Yunnan Huaping to Lijiang Expressway project, which is currently in the debugging phase[13] - The company received CNY 65,126,182.21 from the sale of equity in Yibang International as of the first quarter of 2022[14] - The company reported investment income of CNY 2,038,823.75, up from CNY 1,618,807.37, representing a growth of approximately 25.9%[22] Research and Development - Research and development expenses for Q1 2022 were CNY 7,479,962.26, slightly up from CNY 7,245,382.00 in Q1 2021, indicating an increase of about 3.24%[21] Stock and Audit - The company reported a total of 28,616,623 shares under lock-up, with 27,813,840 shares classified as post-IPO restricted shares[12] - The company has implemented a stock option incentive plan, with the first grant registration completed on January 4, 2022[14] - The company did not conduct an audit for the first quarter report[27]